Search results for "Lung"

showing 10 items of 2389 documents

TA-MUC1 epitope in non-small cell lung cancer

2007

MUC1 (CD227), an established tumor marker, is expressed on glandular epithelia and on epithelial tumors. Tumor MUC1 differs from normal MUC1 by modified glycan side chains. Recently, a novel carbohydrate-induced conformational tumor-associated MUC1 epitope (TA-MUC1) was described, whose clinical relevance in lung cancer is not known. Eighty-five paraffin embedded tissue sections of non-small cell lung cancer (NSCLC) patients (73% male; mean age 64+/-9 years) were stained with the monoclonal antibody PankoMab (against TA-MUC1) and compared with the established antibodies E29 and 214D4 regarding prognostic relevance. TA-MUC1 is virtually absent in bronchial epithelium. As shown by multivariat…

MalePulmonary and Respiratory MedicineCancer ResearchPathologymedicine.medical_specialtyLung Neoplasmsmedicine.drug_classMonoclonal antibodydigestive systemAntibodiesEpitopeEpitopesCarcinoma Non-Small-Cell LungCarcinomamedicineHumansskin and connective tissue diseasesLung cancerneoplasmsLymph nodeMUC1AgedTumor markerbiologybusiness.industryMucin-1Antibodies MonoclonalMiddle AgedPrognosismedicine.diseaseImmunohistochemistrybiological factorsdigestive system diseasesTreatment Outcomemedicine.anatomical_structureOncologyLymphatic Metastasisbiology.proteinFemaleAntibodybusinessLung Cancer
researchProduct

Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale

2002

Abstract Introduction: Platinum-based chemotherapy is the gold standard in advanced non-small cell lung cancer (NSCLC), although with relevant toxic effects. Both docetaxel (DCT) and gemcitabine (GEM) have shown activity as single agent in advanced NSCLC with a different toxicity profile and a lack of cross-resistance. Materials and methods: From April 2000 to May 2001, 47 consecutive patients were enrolled in a multicenter phase II trial. Main inclusion criteria included untreated patients with histologically confirmed NSCLC, age⩽70 years, stage IIIB/IV, Eastern Cooperative Oncology Group performance status (PS) 0–2, measurable disease, adequate hematologic, cardiac, hepatic and renal func…

MalePulmonary and Respiratory MedicineCancer Researchmedicine.medical_specialtyLung NeoplasmsNeutropeniaCost ControlPaclitaxelSurvivalmedicine.medical_treatmentPhases of clinical researchDocetaxelNeutropeniaDeoxycytidineGastroenterologyDrug CostsCarcinoma Non-Small-Cell LungInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineMucositisHumansLung cancerAgedChemotherapybusiness.industryMiddle Agedmedicine.diseaseGemcitabineGemcitabineSurgeryTreatment OutcomeOncologyDocetaxelDisease ProgressionFemaleTaxoidsbusinessProgressive diseasemedicine.drugLung Cancer
researchProduct

A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with che…

2013

Abstract Introduction Tigatuzumab, a humanized monoclonal DR5 agonist antibody induces apoptosis in human cancer cell lines. The objective of this study was to investigate the antitumor effects of tigatuzumab combined with carboplatin/paclitaxel in chemotherapy-naive patients with metastatic/unresectable non-small cell lung cancer (NSCLC). Methods Patients with histologically or cytologically confirmed NSCLC stage IIIB/IV disease by RECIST (version 1.0) and ECOG-PS 0–1 were enrolled at 15 European sites. Patients received tigatuzumab or placebo intravenously with carboplatin/paclitaxel every 3 weeks (1 cycle) for up to 6 cycles. The primary end point was progression-free survival (PFS). Sec…

MalePulmonary and Respiratory MedicineCancer Researchmedicine.medical_specialtyLung NeoplasmsNeutropeniaPaclitaxelmedicine.medical_treatmentPhases of clinical researchNeutropeniaAntibodies Monoclonal HumanizedPlaceboGastroenterologyDisease-Free SurvivalCarboplatinPlaceboschemistry.chemical_compoundDouble-Blind MethodCarcinoma Non-Small-Cell LungInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansNeoplasm MetastasisTigatuzumabLung cancerNeoplasm StagingChemotherapybusiness.industryMiddle Agedmedicine.diseaseCarboplatinSurgeryEuropeReceptors TNF-Related Apoptosis-Inducing LigandOncologychemistryPaclitaxelFemalebusinessLung Cancer
researchProduct

Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency

2012

Background Vitamin D has effects on the innate and adaptive immune system. In asthmatic children low vitamin D levels are associated with poor asthma control, reduced lung function, increased medication intake, and exacerbations. Little is known about vitamin D in adult asthma patients or its association with asthma severity and control. Methods Clinical parameters of asthma control and 25-hydroxyvitamin D (25(OH)D) serum concentrations were evaluated in 280 adult asthma patients (mean ± SD: 45.0 ± 13.8 yrs., 40% male, FEV1 74.9 ± 23.4%, 55% severe, 51% uncontrolled). Results 25(OH)D concentrations in adult asthmatics were low (25.6 ±11.8 ng/ml) and vitamin D insufficiency or deficiency (vi…

MalePulmonary and Respiratory MedicineCross-sectional studyAsthma severityBMIimmune system diseasesForced Expiratory VolumeAsthma controlPrevalenceVitamin D and neurologyHumansCorticosteroidsMedicineProspective StudiesVitamin DProspective cohort studyLung functionAgedCalcifediolAsthmabusiness.industryResearchBody WeightSputumMiddle AgedVitamin D DeficiencyAcquired immune systemmedicine.diseaseAsthmaInterleukin-10respiratory tract diseasesEosinophilsCross-Sectional StudiesImmunologyFemalebusinessRespiratory Research
researchProduct

High-resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD

2012

<b><i>Background:</i></b> The literature shows conflicting results when high-resolution computed tomography (HRCT) scores of emphysema were correlated with different indices of airflow obstruction. <b><i>Objectives:</i></b> We correlated HRCT scores of emphysema with different indices of airflow obstruction. <b><i>Methods:</i></b> We performed HRCT of the chest in 59 patients, all smokers or ex-smokers, with stable chronic obstructive pulmonary disease of different severity [GOLD stages I–IV; mean age ± SD 67.8 ± 7.3 years; pack/years 51.0 ± 34.6; percent predicted forced expiratory volume in 1 s (FEV<sub>1</su…

MalePulmonary and Respiratory MedicineEmphysema COPD High-resolution computed tomography Lung structural alterationsVital capacityHigh-resolution computed tomographyPulmonary diseaseLung structural alterationsSeverity of Illness IndexPulmonary Disease Chronic ObstructiveFEV1/FVC ratioSeverity of illnessmedicineHumansCOPDLung volumesLung functionHigh-resolution computed tomographyAgedEmphysemaCOPDmedicine.diagnostic_testbusiness.industryChronic obstructive pulmonary diseaseSmokingrespiratory systemmedicine.diseaseBronchodilator AgentsRespiratory Function Testsrespiratory tract diseasesPulmonary EmphysemaAnesthesiaMultivariate AnalysisFemaleTomography X-Ray ComputedbusinessNuclear medicineChronic obstructive pulmonary disease; Emphysema; High-resolution computed tomography; Lung structural alterations;
researchProduct

Assessment of Lung Cancer Development in Idiopathic Pulmonary Fibrosis Patients Using Quantitative High-Resolution Computed Tomography:A Retrospectiv…

2020

Purpose The purpose of this study was to investigate histogram-based quantitative high-resolution computed tomography (HRCT) indexes in the assessment of lung cancer (LC) development in idiopathic pulmonary fibrosis (IPF) patients. Materials and methods From IPF databases of 2 national respiratory centers, we retrospectively studied patients with and without LC development-respectively, divided into Group A (n=16) and Group B (n=33). The extent of fibrotic disease was quantified on baseline and follow-up HRCT examinations using kurtosis, skewness, percentage of high attenuation area (HAA%), and percentage of fibrotic area (FA%). These indexes were compared between the 2 groups using the Man…

MalePulmonary and Respiratory MedicineHigh-resolution computed tomography030204 cardiovascular system & hematologylung neoplasmsSensitivity and Specificity030218 nuclear medicine & medical imaging03 medical and health sciencesIdiopathic pulmonary fibrosis0302 clinical medicineFibrosismedicineRetrospective analysisHumansRadiology Nuclear Medicine and imagingusual interstitial pneumoniaLung cancerLungmultidetectorAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testbusiness.industryRetrospective cohort studycomputed tomographyMiddle Agedmedicine.diseaseidiopathic pulmonary fibrosisDisease ProgressionMann–Whitney U testKurtosisFemaleTomography X-Ray ComputedNuclear medicinebusiness
researchProduct

Patterns and predictors of low physical activity in patients with stable COPD: a longitudinal study

2020

Background: Despite the frequency and negative impact of low physical activity among patients with chronic obstructive pulmonary disease (COPD), little is known about how it persists and remits over time or the factors predicting new states of low physical activity. The aim of the study was to determine the probability of a transition between states of low and nonlow physical activity in a cohort of patients with stable COPD followed for 2 years. We also investigated different potentially modifiable factors to determine whether they can predict new states of low physical activity. Methods: We prospectively included 137 patients with stable COPD (mean age 66.9 ± 8.3 years). Physical activity…

MalePulmonary and Respiratory MedicineLongitudinal studymedicine.medical_specialtyTime FactorsHealth StatusPhysical activityphysical activityPulmonary diseasePulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineCOPDHumansMedicinePharmacology (medical)In patientLongitudinal StudiesProspective Studies030212 general & internal medicineExerciseLungOriginal ResearchAgedlcsh:RC705-779COPDbusiness.industrytransitionlcsh:Diseases of the respiratory systemdyspneaMiddle AgedPrognosismedicine.disease5STS030228 respiratory systemDisease ProgressionFemaleSedentary BehaviorbusinessTherapeutic Advances in Respiratory Disease
researchProduct

Decreased FOXP3 expression in small airways of smokers with COPD

2008

CD4+CD25+ FOXP3-positive T-regulatory cells have an important role in controlling immune and inflammatory reactions. The present authors hypothesise that these cells may be involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). The aim of the present study was to characterise the expression of FOXP3 in large and small airways of nonsmokers, smokers with normal lung function and COPD patients. A total of 19 nonsmokers, 20 smokers with normal lung function and 20 smokers with moderate COPD, undergoing lung resection for a solitary peripheral nonsmall cell carcinoma, were enrolled in the study. Immunohistochemical methods were used to evaluate FOXP3 expression in large a…

MalePulmonary and Respiratory MedicineLung NeoplasmsBronchiAsymptomaticPathogenesisPulmonary Disease Chronic ObstructiveImmune systemCarcinoma Non-Small-Cell LungForced Expiratory VolumemedicineCarcinomaHumansIL-2 receptorAgedCOPDbusiness.industrySmokingCase-control studyFOXP3Forkhead Transcription FactorsMiddle Agedrespiratory systemmedicine.diseaserespiratory tract diseasesCase-Control StudiesImmunologyFemalemedicine.symptombusinessEuropean Respiratory Journal
researchProduct

Expression of KIT (CD117) in Biphasic Pulmonary Blastoma. Novel Data on Histogenesis

2003

Biphasic pulmonary blastoma (BPB) is a rare primary neoplasm of the lung and its histogenesis is still uncertain. It has been proposed that BPB is derived from mesoderm or endoderm. Others suggested an origin from a single pluripotential cell. We present a case of a BPB with emphasis on expression of the stem cell factor receptor KIT (CD117). We describe a 61-year-old male patient with a BPB of the upper right lobe. Immunohistochemical analysis was performed using a panel of several antibodies including anti-CD117. Strong cytoplasmic expression of CD117 was found in the epithelium (cytokeratin-positive) as well as in the spindle cells (cytokeratin-negative). Expression of CD117 in both mese…

MalePulmonary and Respiratory MedicineMesodermPathologymedicine.medical_specialtyLung NeoplasmsStromal cellbiologyCD117Biphasic Pulmonary BlastomaMesenchymal stem cellStem cell factorMiddle AgedHistogenesisImmunohistochemistrydigestive system diseasesProto-Oncogene Proteins c-kitmedicine.anatomical_structurebiology.proteinmedicineHumansEndodermLungLung
researchProduct

Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury

2012

ckground information: Bone marrow-derived mesenchymal stem cells (MSCs) reduce acute lung injury in animals challenged by bleomycin or bacterial lipopolysaccaride. It is not known, however, whether MSCs protect from ventilator- induced lung injury (VILI). Question of the study: Whether MSCs have a potential role in preventing or modulating VILI in healthy rats subjected to high-volume ventilation. Materials and methods: 24 Sprague-Dawley rats (250-300 g) were subjected to high- volume mechanical ventilation (25 ml/kg). MSCs (5x106) were intravenously or intratracheally administered (N=8 each) 30 min before starting over-ventilation and 8 rats were MSC-untreated. Spontaneously breathing anes…

MalePulmonary and Respiratory MedicinePathologymedicine.medical_specialtyAdministration TopicalVentilator-Induced Lung Injurymedicine.medical_treatmentVascular Cell Adhesion Molecule-1Pulmonary EdemaSettore MED/10 - Malattie Dell'Apparato RespiratorioLung injuryMesenchymal Stem Cell TransplantationBleomycinRats Sprague-Dawley03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAcute lung injury cell therapy injurious ventilation lung edema lung inflammation mechanical ventilationAnimalsMedicineMacrophageCell adhesionLung030304 developmental biologyMechanical ventilation0303 health sciencesmedicine.diagnostic_testbusiness.industryMesenchymal stem cellrespiratory systemRatsrespiratory tract diseasesDisease Models AnimalBronchoalveolar lavage030228 respiratory systemchemistryBreathingAdministration IntravenousInflammation MediatorsbusinessBronchoalveolar Lavage FluidEuropean Respiratory Journal
researchProduct